PR Newswire Clinical TrialsOriginal article
Probably Genetic Awarded Up to $10M ARPA-H Contract to End the Rare Disease Diagnostic Odyssey with AI
PartnershipPositive
AI Analysis
Summary
Probably Genetic received up to $10M in ARPA-H contract funding through the RAPID program to scale its AI platform for rare disease diagnosis, research, and treatment.
Outcome Details
Up to $10M contract award as part of ARPA-H RAPID program
Importance:6/10
Sentiment:
0.70
rare_diseasediagnosticAI_platformgovernment_fundingARPA-HRAPID_program
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 31, 2026 4:03 PM